The SUMO E3 Ligase CBX4 is Identified As a Poor Prognostic Marker of Gastric Cancer Through Multipronged OMIC Analyses

Overview

Journal Genes Dis

Date 2021 Sep 15

PMID 34522711

Citations 10

Authors

Yi Pan

Qingshang Li

Zhijun Cao

Shuliang Zhao

Affiliations

Soon will be listed here.

Abstract

Gastric cancer (GC) is one of the most common malignancies, with an ever-increasing incidence and high mortality rate. Chromobox4 (CBX4), also named hPC2, is a small ubiquitin-related modifier (SUMO) E3 ligase. Previous studies have found that high CBX4 expression is associated with tumor size, pathologic differentiation and decreased patient survival in hepatocellular carcinoma (HCC). However, the expression and prognostic value of CBX4 in GC have not been clarified. In our study, ONCOMINE, UALCAN, Kaplan-Meier Plotter, cBioPortal, DAVID 6.8 and TIMER were utilized. RT-PCR, immunohistochemistry (IHC), Western blot, CCK-8 assay, cell apoptosis assay, cell cycle assay were used to further verify in GC tissue samples or cell line. The transcriptional and protein level of CBX4 in GC tissues was found significantly elevated and a significant association between the expression of CBX4 and clinicopathological parameters was found in GC patients. Low expression of CBX4 in GC patients were correlated with a significantly improved prognosis. The functions of CBX4 are primarily related to the stem cell pluripotency signaling pathway, Hippo signaling pathway, HTLV-I infection, Notch signaling pathway, and N-glycan biosynthesis. Our results may provide novel insights for the selection of therapeutic targets and prognostic biomarkers for GC.

Citing Articles

Formononetin suppresses the malignant progression of papillary thyroid carcinoma depending on downregulation of CBX4.

Yu H, Qu J, Gou H, Zhou Y Exp Ther Med. 2024; 28(6):456.

PMID: 39478737 PMC: 11523267. DOI: 10.3892/etm.2024.12746.

CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.

Zhao R, Guo Y, Zhang L, Huang Z, Li X, Lan B Cell Death Dis. 2024; 15(5):378.

PMID: 38816356 PMC: 11140001. DOI: 10.1038/s41419-024-06745-z.

Comprehensive analysis of prognostic value and immune infiltration of Regulator of Chromosome Condensation 2 in lung adenocarcinoma.

Lin H, Lin G, Lin L, Yang J, Yang D, Lin Q J Cancer. 2024; 15(7):1901-1915.

PMID: 38434981 PMC: 10905397. DOI: 10.7150/jca.91367.

ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression.

Shi L, Shangguan J, Lu Y, Rong J, Yang Q, Yang Y J Transl Med. 2024; 22(1):148.

PMID: 38351014 PMC: 10863176. DOI: 10.1186/s12967-024-04913-5.

SUMOtherapeutics for Ischemic Stroke.

Karandikar P, Gerstl J, Kappel A, Won S, Dubinski D, Garcia-Segura M Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242456 PMC: 10221934. DOI: 10.3390/ph16050673.

References

Muller J, Verrijzer P . Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr Opin Genet Dev. 2009; 19(2):150-8. DOI: 10.1016/j.gde.2009.03.001. View

Yang J, Cheng D, Zhu B, Zhou S, Ying T, Yang Q . Chromobox Homolog 4 is Positively Correlated to Tumor Growth, Survival and Activation of HIF-1α Signaling in Human Osteosarcoma under Normoxic Condition. J Cancer. 2016; 7(4):427-35. PMC: 4749363. DOI: 10.7150/jca.13749. View

Lee H, Kim W, Kwak Y, Koh J, Bae J, Kim K . Molecular Testing for Gastrointestinal Cancer. J Pathol Transl Med. 2017; 51(2):103-121. PMC: 5357760. DOI: 10.4132/jptm.2017.01.24. View

Chon S, Berlth F, Plum P, Herbold T, Alakus H, Kleinert R . Gastric cancer treatment in the world: Germany. Transl Gastroenterol Hepatol. 2017; 2:53. PMC: 5460150. DOI: 10.21037/tgh.2017.05.07. View

Gyorffy B, Surowiak P, Budczies J, Lanczky A . Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013; 8(12):e82241. PMC: 3867325. DOI: 10.1371/journal.pone.0082241. View

Ismail I, Gagne J, Caron M, McDonald D, Xu Z, Masson J . CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucleic Acids Res. 2012; 40(12):5497-510. PMC: 3384338. DOI: 10.1093/nar/gks222. View

White I, Royston P . Imputing missing covariate values for the Cox model. Stat Med. 2009; 28(15):1982-98. PMC: 2998703. DOI: 10.1002/sim.3618. View

Aloia L, Di Stefano B, Di Croce L . Polycomb complexes in stem cells and embryonic development. Development. 2013; 140(12):2525-34. DOI: 10.1242/dev.091553. View

Gao J, Aksoy B, Dogrusoz U, Dresdner G, Gross B, Sumer S . Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269):pl1. PMC: 4160307. DOI: 10.1126/scisignal.2004088. View

10.

Ma R, Zhang Y, Sun T, Cheng B . Epigenetic regulation by polycomb group complexes: focus on roles of CBX proteins. J Zhejiang Univ Sci B. 2014; 15(5):412-28. PMC: 4076598. DOI: 10.1631/jzus.B1400077. View

11.

Mardaryev A, Liu B, Rapisarda V, Poterlowicz K, Malashchuk I, Rudolf J . Cbx4 maintains the epithelial lineage identity and cell proliferation in the developing stratified epithelium. J Cell Biol. 2015; 212(1):77-89. PMC: 4700479. DOI: 10.1083/jcb.201506065. View

12.

Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y . Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann Surg Oncol. 2013; 20 Suppl 3:S684-92. DOI: 10.1245/s10434-013-3171-7. View

13.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

14.

Richly H, Aloia L, Di Croce L . Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis. 2011; 2:e204. PMC: 3186902. DOI: 10.1038/cddis.2011.84. View

15.

Szasz A, Lanczky A, Nagy A, Forster S, Hark K, Green J . Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 2016; 7(31):49322-49333. PMC: 5226511. DOI: 10.18632/oncotarget.10337. View

16.

Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

17.

Yang L, Lin C, Liu W, Zhang J, Ohgi K, Grinstein J . ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011; 147(4):773-88. PMC: 3297197. DOI: 10.1016/j.cell.2011.08.054. View

18.

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

19.

Strand M, Lockhart A, Fields R . Genetics of Gastric Cancer. Surg Clin North Am. 2017; 97(2):345-370. DOI: 10.1016/j.suc.2016.11.009. View

20.

Li J, Xu Y, Long X, Wang W, Jiao H, Mei Z . Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell. 2014; 25(1):118-31. DOI: 10.1016/j.ccr.2013.12.008. View